Luxembourg: 3B Future Health launches fund to specialise on oncology start ups

3B Future Health has launched 3B Future Health Fund II, a fund that will focus on early-stage investment opportunities in the US and Europe. It will target investments in start-ups specialising in oncology and rare disease therapeutics. The latest fund follows on from an earlier Fund I, formerly known as Helsinn Investment Fund, and is…

You must be a HMI Subscriber to view this content.

Subscribe Now »